Terazosin hydrochloride

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Terazosin 是一种选择性 α1 拮抗剂，用于治疗良性前列腺增生 (BPH) 症状。

Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.(In Vitro):Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells.(In Vivo):Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm.

Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells.

Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm.

Terazocin HCl | Vasocard | Hyprin | A-45975 | A 45975 | A45975

Endocrinology/Hormones

Adrenergic Receptor

α-adrenergic receptor

Metabolic Disease

——

63074-08-8

423.89

C19H26ClN5O4

>98% (HPLC)

Water: 50 mM

O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4.[H]Cl

Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride

(-20℃)

With Ice Pack

≥ 2 years